State Of Wyoming Immunocore Holdings PLC Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$25.46 - $37.72 $1,323 - $1,961	52 Added 31.9%	215 $8,000
Q1 2022 May 13, 2022	BUY	$18.94 - $34.29 $511 - $925	27 Added 19.85%	163 $5,000
Q4 2021 Feb 11, 2022	SELL	$27.58 - $40.0 $193 - $280	-7 Reduced 4.9%	136 $5,000
Q3 2021 Feb 11, 2022	SELL	$27.98 - $40.0 $1,930 - $2,760	-69 Reduced 32.55%	143 $5,000
Q2 2021 Feb 11, 2022	BUY	$32.22 - $41.5 $6,830 - $8,798	212 New	212 $8,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.